Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1Breceptor antagonists: TASP0233278 and TASP0390325

The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors

(2013) Stephen P.H. Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

The Vasopressin V1bReceptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders

(2012) Guy Griebel et al.   JOURNAL OF CLINICAL PSYCHIATRY

Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines

(2011) Carol Kilkenny et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Pharmacological characterization of repeated corticosterone injection-induced depression model in rats

(2010) Michihiko Iijima et al.   BRAIN RESEARCH

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

A selective, non-peptide CRF receptor 1 antagonist prevents sodium lactate-induced acute panic-like responses

(2010) Anantha Shekhar et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Assessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming test

(2010) Stella Chaviaras et al.   PSYCHOPHARMACOLOGY

Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist

(2009) Robert H. Ring et al.   NEUROPHARMACOLOGY